Dolby Laboratories, Inc. (DLB) Balance sheet

Market cap

$5.9B

P/E ratio

	2010/09	2011/09	2012/09	2013/09	2014/09	2015/09	2016/09	2017/09	2018/09	2019/09	2020/09	2021/09	2022/09	2023/09	2024/09
Cash and cash equivalents	546	552	493	454	568	532	516	627	918	806	1,080	1,233	628	818	578
Marketable securities, current	302	391	303	140	231	139	122	248	178	119	47	39	189	139	-
Total cash & short-term investments	848	943	795	595	800	671	638	875	1,096	925	1,127	1,272	818	957	578
Accounts receivable, net	54	62	43	97	86	102	76	74	137	189	180	233	244	262	315
Inventories	28	26	17	10	9	14	16	25	26	32	26	11	24	36	34
Total current assets	1,060	1,159	970	813	1,006	918	760	1,011	1,302	1,382	1,547	1,760	1,311	1,488	1,194
Property, plant and equipment, net	94	117	255	243	290	403	444	485	514	537	542	534	513	482	479
Marketable securities, non-current	191	273	362	306	296	321	394	314	188	180	52	63	103	98	89
Total non-current assets	651	726	991	925	978	1,215	1,550	1,522	1,357	1,440	1,370	1,345	1,379	1,492	1,916
Total assets	1,712	1,884	1,961	1,738	1,984	2,133	2,310	2,534	2,659	2,822	2,917	3,106	2,690	2,980	3,110
Accounts payable	4	11	15	11	16	21	18	14	22	15	13	18	14	21	17
Total current liabilities	166	159	157	173	189	210	213	246	272	307	267	316	278	422	418
Total non-current liabilities	51	40	61	65	63	108	118	144	191	202	212	186	161	185	205
Total liabilities	217	199	218	238	252	317	331	390	463	509	479	501	439	608	623
Retained earnings	1,136	1,445	1,709	1,454	1,660	1,801	1,938	2,083	2,139	2,328	2,443	2,608	2,298	2,392	2,496
Stockholders' equity	1,495	1,685	1,743	1,500	1,732	1,816	1,979	2,144	2,196	2,313	2,438	2,604	2,251	2,372	2,487
Working capital